Skip to main content
Top
Published in: Clinical Rheumatology 5/2009

01-05-2009 | Original Article

Increased frequencies of hysterectomy and early menopause in fibromyalgia patients: a comparative study

Authors: Ömer Nuri Pamuk, Salim Dönmez, Necati Çakir

Published in: Clinical Rheumatology | Issue 5/2009

Login to get access

Abstract

The objective was to determine the relationship between symptoms of fibromyalgia (FM) and early menopause and hysterectomy. We included 115 postmenopausal patients with FM (mean age 54.6 ± 7.6) and 67 rheumatoid arthritis (RA) patients (mean age 55.5 ± 9) into our study. All patients were questioned about the severity of their symptoms of FM, anxiety, and depression by using a visual analog scale and FM impact questionnaire. Patients’ history of menopause and hysterectomy were recorded. Menopause (≤45 years) was accepted to be early. The frequencies of early menopause (38.3% vs. 13.4%, p = 0.001) and hysterectomy (16.5% vs. 6%, p = 0.039) in FM patients were significantly higher than in RA patients. While chronic widespread pain and other FM-related symptoms started after menopause in 58.3% of FM patients, the disease started after menopause in 64.2% of RA patients (p > 0.05). FM-related symptoms started in 30 patients (26.1%) with FM with menopause or within the first postmenopausal year. When the clinical features of FM patients whose symptoms started within the first menopausal year were compared to other FM patients; it was observed that the frequency of early menopause was higher in the former group (p = 0.048). Duke anxiety and depression score was higher in patients with hysterectomy whose FM symptoms started within the first year of post-hysterectomy than other FM patients (9.1 ± 2.7 vs. 6.7 ± 2.7, p = 0.022). Early menopause and hysterectomy may be one of the factors contributing to the development of FM.
Literature
1.
go back to reference Croft P, Rigby AS, Boswell R, Schollum J, Silman A (1993) The prevalence of chronic widespread pain in the general population. J Rheumatol 20:710–713PubMed Croft P, Rigby AS, Boswell R, Schollum J, Silman A (1993) The prevalence of chronic widespread pain in the general population. J Rheumatol 20:710–713PubMed
2.
go back to reference Khan MF (2006) Does hormone replacement therapy discontinuation cause musculoskeletal pain? Joint Bone Spine 73:488–489CrossRef Khan MF (2006) Does hormone replacement therapy discontinuation cause musculoskeletal pain? Joint Bone Spine 73:488–489CrossRef
3.
4.
go back to reference Pamuk ON, Cakir N (2005) The variation in chronic widespread pain and other symptoms in fibromyalgia patients. The effects of menses and menopause. Clin Exp Rheumatol 23:778–782PubMed Pamuk ON, Cakir N (2005) The variation in chronic widespread pain and other symptoms in fibromyalgia patients. The effects of menses and menopause. Clin Exp Rheumatol 23:778–782PubMed
5.
go back to reference Waxman J, Zatzkis SM (1986) Fibromyalgia and menopause. Examination of the relationship. Postgrad Med 80:165–171PubMed Waxman J, Zatzkis SM (1986) Fibromyalgia and menopause. Examination of the relationship. Postgrad Med 80:165–171PubMed
6.
go back to reference Ockene JK, Barad DH, Cochrane BB et al (2005) Symptom experience after discontinuing use of estrogen plus progestin. JAMA 294:183–193PubMedCrossRef Ockene JK, Barad DH, Cochrane BB et al (2005) Symptom experience after discontinuing use of estrogen plus progestin. JAMA 294:183–193PubMedCrossRef
7.
go back to reference Felson DT, Cummings SR (2005) Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation. Arthritis Rheum 52:2594–2598PubMedCrossRef Felson DT, Cummings SR (2005) Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation. Arthritis Rheum 52:2594–2598PubMedCrossRef
8.
go back to reference Ribot C, Tremollieres F, Pouilles JM (2006) Aromatase and regulation of bone remodeling. Joint Bone Spine 73:37–42PubMedCrossRef Ribot C, Tremollieres F, Pouilles JM (2006) Aromatase and regulation of bone remodeling. Joint Bone Spine 73:37–42PubMedCrossRef
9.
go back to reference Geenen R, Jacobs JW, Bijlsma JW (2002) Evaluation and management of endocrine dysfunction in fibromyalgia. Rheum Dis Clin North Am 28:389–404PubMedCrossRef Geenen R, Jacobs JW, Bijlsma JW (2002) Evaluation and management of endocrine dysfunction in fibromyalgia. Rheum Dis Clin North Am 28:389–404PubMedCrossRef
10.
go back to reference ter Borg EJ, Gerards-Rociu E, Haanen HC, Westers P (1999) High frequency of hysterectomies and appendectomies in fibromyalgia compared with rheumatoid arthritis: a pilot study. Clin Rheumatol 18:1–3PubMedCrossRef ter Borg EJ, Gerards-Rociu E, Haanen HC, Westers P (1999) High frequency of hysterectomies and appendectomies in fibromyalgia compared with rheumatoid arthritis: a pilot study. Clin Rheumatol 18:1–3PubMedCrossRef
11.
go back to reference Wolfe F, Smythe HA, Yunus MB et al (1990) The American Colloge of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 33:160–172PubMedCrossRef Wolfe F, Smythe HA, Yunus MB et al (1990) The American Colloge of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 33:160–172PubMedCrossRef
12.
go back to reference Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef
13.
go back to reference Parkerson GJ, Broadhead WE, Tse CK (1996) Anxiety and depression symptom identification using the Duke Health Profile. J Clin Epidemiol 49:85–93PubMedCrossRef Parkerson GJ, Broadhead WE, Tse CK (1996) Anxiety and depression symptom identification using the Duke Health Profile. J Clin Epidemiol 49:85–93PubMedCrossRef
14.
go back to reference Burckhardt CS, Clark SR, Bennett RM (1991) The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 18:728–733PubMed Burckhardt CS, Clark SR, Bennett RM (1991) The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 18:728–733PubMed
15.
go back to reference Sarmer S, Ergin S, Yavuzer G (2000) The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 20:9–12PubMedCrossRef Sarmer S, Ergin S, Yavuzer G (2000) The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 20:9–12PubMedCrossRef
16.
go back to reference Rossouw JE, Anderson GL, Prentice RL et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288:321–333PubMedCrossRef Rossouw JE, Anderson GL, Prentice RL et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288:321–333PubMedCrossRef
17.
go back to reference Blomqvist A (2000) Sex hormones and pain: a new role for brain aromatase. J Comp Neurol 423:549–551PubMedCrossRef Blomqvist A (2000) Sex hormones and pain: a new role for brain aromatase. J Comp Neurol 423:549–551PubMedCrossRef
18.
go back to reference Salem ML (2004) Estrogen, a double-edged sword: modulation of TH1- and TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production. Curr Drug Targets Inflamm Allergy 3:97–104PubMedCrossRef Salem ML (2004) Estrogen, a double-edged sword: modulation of TH1- and TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production. Curr Drug Targets Inflamm Allergy 3:97–104PubMedCrossRef
20.
go back to reference Macfarlane TV, Blinkhorn A, Worthington HV, Davies RM, Macfarlane GJ (2002) Sex hormonal factors and chronic widespread pain: a population study among women. Rheumatology (Oxford) 41:454–457CrossRef Macfarlane TV, Blinkhorn A, Worthington HV, Davies RM, Macfarlane GJ (2002) Sex hormonal factors and chronic widespread pain: a population study among women. Rheumatology (Oxford) 41:454–457CrossRef
Metadata
Title
Increased frequencies of hysterectomy and early menopause in fibromyalgia patients: a comparative study
Authors
Ömer Nuri Pamuk
Salim Dönmez
Necati Çakir
Publication date
01-05-2009
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 5/2009
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-009-1087-1

Other articles of this Issue 5/2009

Clinical Rheumatology 5/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine